APA (7th ed.) Citation

DJ, B., NG, C., PF, E., N, E., E, F., LN, P., . . . EA, M. (2025). Updated favourable-histology Wilms tumour risk stratification: Rationale for future Children's Oncology Group clinical trials. Nature reviews. Urology, 22(11), 775. https://doi.org/10.1038/s41585-025-01055-1

Chicago Style (17th ed.) Citation

DJ, Benedetti, et al. "Updated Favourable-histology Wilms Tumour Risk Stratification: Rationale for Future Children's Oncology Group Clinical Trials." Nature Reviews. Urology 22, no. 11 (2025): 775. https://doi.org/10.1038/s41585-025-01055-1.

MLA (9th ed.) Citation

DJ, Benedetti, et al. "Updated Favourable-histology Wilms Tumour Risk Stratification: Rationale for Future Children's Oncology Group Clinical Trials." Nature Reviews. Urology, vol. 22, no. 11, 2025, p. 775, https://doi.org/10.1038/s41585-025-01055-1.